Anlit and POLPHARMA Signed an Exclusive Agreement
According to PMR Publications, the dietary supplements market in Poland was worth over €484m in 2008, an increase of 24% from 2007. The market is forecast to expand by 12–15% per annum through 2011.
29 Jan 2010 --- Anlit Ltd. (Israel) and Polpharma Ltd. (Poland) have signed an exclusive agreement to market Anlit’s innovative supplements for toddlers and children, Acidolac Junior, in pharmacies across Poland. Polpharma will distribute the Anlit products through Medana, a subsidiary specializing in marketing vitamin products through pharmacies.
According to PMR Publications, the dietary supplements market in Poland was worth over €484m in 2008, an increase of 24% from 2007. The market is forecast to expand by 12–15% per annum through 2011 despite the financial crisis and the anticipated consequences of upcoming regulatory changes.
“The Anlit supplement line for children presents an innovative concept in combining great taste with wellness benefits,” says Krzysztof Jakubiak, PR Director at Polpharma.”It complements our Acidolac line for babies and enables us to target the children market as well.”
“We are convinced that Polpharma, with the firm reputation it built over the decades and its very strong presence in the dietary supplements market, offers added-value products and services; this is an important parameter in choosing a partner to market our products”, says Shai Karlinski, VP Marketing for Anlit.
